2Bugianesi E,Leone N,Vanni E,Marchesini G,Brunello F,Carucci P,Musso A,De Paolis P,Capussotti L,Salizzoni M,Rizzetto M.Expanding the natural history of nonalcoholic steatohepatitis:from cryptogenic cirrhosis to hepatocellular carcinoma.Gastroenterology,200
3Sohda T,Kamimura S,Iwata K,Shijo H,Okumura M.Immunohistochemical evidence of insulin-like growth factor Ⅱ in human small hepatocellular carcinoma with hepatitis C virus infection:relationship to fatty change in carcinoma cells.J Gastroenterol Hepatol,199
4Calle EE,Rodriguez C,Walker-Thurmond K,Thun MJ.Overweight,obesity,and mortality from cancer in a prospectively studied cohort of U.S.adults.N Engl J Med,2003,348:1625-1638.
5Matteoni CA,Younossi ZM,Gramlich T,Boparai N,Liu YC,McCullough AJ.Nonalcoholic fatty liver disease:a spectrum of clinical and pathological severity.Gastroenterology,1999,116:1413-1419.
6Marrero JA,Fontana RJ,Su GL,Conjeevaram HS,Emick DM,Lok AS.NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States.Hepatology,2002,36:1349-1354.
2Yan Qian and Jian-Gao Fan Shanghai, China Center for Fatty Liver Disease, First People’ s Hospi- tal , Shanghai Jiaotong University, Shanghai 200080, China.Obesity, fatty liver and liver cancer[J].Hepatobiliary & Pancreatic Diseases International,2005,4(2):173-177. 被引量：11
